BCB
SYK icon

Brian C. Broderick’s Stryker SYK Stock Holding History

Brian C. Broderick’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-625
Closed -$205K – 98
2026
Q1 		$205K Buy
+625
New +$224K 0.04% 90

Other funds holding SYK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brian C. Broderick's SYK Position: Q2 2026 in Review

Brian C. Broderick sold out of Stryker (SYK) in Q2 2026, closing a stake of 625 shares — an estimated $205K sold.

Brian C. Broderick first reported a position in SYK in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Brian C. Broderick reported no remaining Stryker position as of Q2 2026 after selling out during the quarter.
  • Brian C. Broderick sold 625 Stryker shares in Q2 2026, an estimated $205K.
  • Brian C. Broderick first reported a position in Stryker in Q1 2026 and held it in 1 quarter.
  • Brian C. Broderick's Stryker position peaked at $205K in Q1 2026.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Brian C. Broderick's 13F filing for Q2 2026, filed 11 Aug 2026.